InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the complete record of transactions filed by Flagship Ventures Fund IV General Partner LLC. Insider active across 3 companies, notably Axcella Health Inc.. In total, 4 disclosures have been recorded. Breakdown: 4 buys · 0 sell. Total volume traded: €11.2m. History available since 16 March 2022. The latest transaction was disclosed on 13 October 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Flagship Ventures Fund IV General Partner LLC is a declarant linked to Evelo Biosciences, Inc. and Axcella Health Inc. The declarant has 4 filings in total, and across the 4 recent sampled filings, buy acquisitions span from 2022-03-18 to 2023-07-13, with buy volume of EUR 11216773 and no sell volume.